Case guide

UPDATED FEB 2026

PowerPort Catheter Fracture — How It Happens

Part of the Bard PowerPort Catheter investigation

The short answer

Bard PowerPort catheters fracture through a well-documented mechanism called environmental stress cracking (ESC) of polyurethane — a process that was scientifically foreseeable at the time of device design. The fracture is silent and painless, meaning most patients have no idea their catheter has broken until complications force diagnostic imaging.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

The Polyurethane Degradation Problem

Polyurethane is a synthetic polymer used by C.R. Bard in the catheter tubing of its PowerPort devices. While polyurethane offers initial flexibility and good biocompatibility, it is fundamentally vulnerable to a degradation process called environmental stress cracking (ESC). ESC occurs when mechanical stress combines with chemical exposure in a biological environment to propagate microscopic cracks through the polymer matrix. Inside the human body, the PowerPort catheter is subjected to relentless mechanical stress from heartbeat-generated pressure waves, respiratory movement, arm and shoulder motion, and arterial pulsation transmitted through surrounding tissue. These forces act on the catheter millions of times per year.

Lipids from surrounding biological tissue are absorbed into the polyurethane polymer. These lipids act as stress-concentrating plasticizers at crack tips, accelerating crack propagation through a phenomenon called lipid-induced stress cracking. Heparin and other flush solutions used to maintain port patency may further degrade the polyurethane surface. Oxidative mechanisms involving metal ions released by metallic port components contribute additional polymer chain scission. The combined result is that over months to years, the catheter wall at high-stress anatomical locations — particularly the clavicle-first rib pinch-off zone — develops progressive cracking until a full-thickness fracture occurs.

Pinch-Off Syndrome: The Mechanical Trigger

The subclavian approach for port catheter placement — used in the majority of PowerPort implantations — routes the catheter through the narrow space between the clavicle and first rib. This anatomical corridor is a mechanical pinch point: every arm elevation, shoulder roll, and deep breath compresses the catheter between these two bony structures. Over time, repetitive compression at this site creates a stress concentration that dramatically accelerates ESC. Radiographic pinch-off is classified on a three-grade scale; Grade III pinch-off — complete catheter occlusion — is strongly associated with catheter fracture and subsequent embolism.

The pinch-off mechanism was documented in the medical literature years before many of the devices currently in litigation were manufactured. Vascular surgeons and interventional radiologists published case series and reviews identifying pinch-off syndrome as a significant hazard of subclavian port placement and polyurethane catheters specifically. This published literature — combined with Bard's internal adverse event reports under 21 CFR Part 803 — establishes that the manufacturer knew or should have known about the fracture risk and failed to take adequate corrective action.

Why Silicone Catheters Do Not Have This Problem

Silicone catheters — used in competing products such as the Hickman catheter and various Mediport devices — do not undergo the same ESC mechanism because silicone polymers have fundamentally different chemical structures that are resistant to lipid-induced stress cracking. Silicone catheters are more flexible and less susceptible to mechanical fatigue fracture in the biological environment. The availability of silicone as a safer design alternative is central to the design defect theory in PowerPort litigation: plaintiffs argue that Bard chose polyurethane over silicone for manufacturing or cost reasons without adequate justification given the known ESC risk, creating a product that was unreasonably dangerous as designed.

Key data

Data & Statistics

3 SOURCED FIGURES

Polyurethane ESC documented in medical literature since the 1990s as a known risk of implantable polyurethane catheters

Journal of Biomedical Materials Research

Grade III pinch-off on chest X-ray associated with 4x increased catheter fracture risk vs. Grade 0

Journal of Vascular and Interventional Radiology

PowerPort MDL includes thousands of fracture plaintiffs as of early 2026

MDL 3:22-md-03062 docket, D. Arizona

FAQ

Frequently Asked Questions

12 QUESTIONS

A Bard PowerPort is a brand of implantable venous access port (IVAP) made by C.R. Bard (now part of Becton Dickinson). It consists of a small reservoir implanted under the chest skin connected to a polyurethane catheter threaded into a large central vein near the heart. The device provides long-term intravenous access for chemotherapy, blood draws, and medication delivery without repeated needle sticks. Millions of patients have received PowerPort devices, with cancer patients being the primary recipients. The defect at the center of current litigation is the polyurethane catheter's susceptibility to fracturing inside the body over time.

Dive deeper

Related Guides

9 GUIDES

The full investigation

Part of the Bard PowerPort Catheter Investigation